UNITED NATIONS
The World Health Organization (WHO) has reported that the drug used to fight breast cancer all over the world can actually be a carcinogenic agent by increasing the risk of contracting endometrial cancer. The disturbing news about Tamoxifen, the medicine given to women after breast cancer operations, was the result of a study consisting of 17 scientists from different countries at the WHO's International Agency for Research of Cancer (IARC) in Lyon, France.
However, Nick Gaudin, spokesperson for IARC says the benefits of Tamoxifen far outweigh its potential risks and women being treated for breast cancer should not stop their treatment.
In spite of criticisms directed against it, the UN is all set to fund the second world conference on human settlements to be held from June 3-14 in Istanbul, Turkey. Considering the state of bankruptcy hat the UN finds itself in, countries like the US have voiced their concern on the UN move. Dismissing them, however, UN officials are at pains to insist that the conference would promote the habitat housing activities worldwide. The UN has sponsored six international conferences so far in six years.
Related Content
- Joint committee report on pollution of Chandlai lake, Jaipur, Rajasthan, 21/11/2024
- Judgment of the National Green Tribunal regarding pollution by Nectar Life Sciences Limited, Sahibzada Ajit Singh Nagar, Punjab, 21/11/2024
- Status report on behalf of Amicus Curiae on pollution by pulp and paper industry in Muzaffar Nagar, Uttar Pradesh, 20/11/2024
- Judgment of the Supreme Court regarding decision to construct a commercial airport in Silchar, Assam, 06/05/2024
- Order of the National Green Tribunal regarding fire breaking out at NTPC's superthermal power plant in Jharkhand, 01/05/2024
- Inspection Report by GPCB regarding Nadiad Nagarpalika SWM site, village Kamla, Manjipura road, Nadiad, Kheda, Gujarat, 26/04/2024